Guillain Barre Syndrome is a rare autoimmune illness that damages peripheral nerves, initially muscle weakness is the common symptom which leads to complete paralysis. It is a devastating disease as it suddenly takes entire body in its grip, early signs are pain, tingling, inappropriate sensations and ascending paralysis in legs. Guillain Barre Syndrome is an overwhelming disease as patients and families get shocked at its speedy attack on the body.
Majority of patients reach the stage of maximum weakness approximately after 2-3 weeks since the early signs appear, therefore by the end of 3-4 week 90% of Guillain Barre Syndrome become weakest and hardly move a muscle. However there are dissimilarities found in the recovery period, few fortunate people demonstrate fast recovery time and get better in few weeks. While for some the recovery time may take as long as several years.
Almost 30% patients experience worst effects like residual weakness even after 3-5 years of Guillain Barre Syndrome.
Approximately 3% suffer a deterioration of muscle, tingling sensations and constant weakness even after many years of the initial attack.
Scientists are focused on finding innovative treatments for Guillain Barre Syndrome and revolutionizing existing treatments. Scientists are also searching to explore new ways to find cells in immune system that start and responsible for this nervous illness.